Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3999664 | Urologic Oncology: Seminars and Original Investigations | 2015 | 11 Pages |
Abstract
Our results suggest that the miR-185, as a tumor suppressor, plays a pivotal role by inhibiting VEGFA in VHL-inactivated ccRCC.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Xin M.D., Donglai M.D., Hongzhao M.D., Yu M.D., Xiangjun M.D., Qingbo M.D., Yu M.D., Xintao M.D., Liangyou M.D., Shaoxi M.D., Xu M.D., Junyao M.D., Xu M.D.,